Cargando…
Carbonic anhydrase inhibitors in the management of macular edema: A review of the literature
BACKGROUND: Macular edema (ME) is a vision-threatening condition that commonly develops as a consequence of ocular diseases, including age-related macular degeneration, retinal vaso-occlusion of the central retinal vein and its branches, diabetic retinopathy, central serous chorioretinopathy, uveiti...
Autor principal: | Shahsuvaryan, Marianne L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Virtual Ophthalmic Research Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445326/ https://www.ncbi.nlm.nih.gov/pubmed/37641698 http://dx.doi.org/10.51329/mehdiophthal1443 |
Ejemplares similares
-
Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis
por: Huang, Qinzhu, et al.
Publicado: (2017) -
Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema
por: Asahi, Masumi G, et al.
Publicado: (2015) -
EFFECT OF ORAL CARBONIC ANHYDRASE INHIBITOR ON CYSTOID MACULAR EDEMA ASSOCIATED WITH RETINITIS PIGMENTOSA: An OCT and OCT Angiography Study
por: Yeo, Joon Hyung, et al.
Publicado: (2022) -
Multivalent Carbonic Anhydrases Inhibitors †
por: Carta, Fabrizio, et al.
Publicado: (2019) -
Glaucomatous Optic Neuropathy Management: the Role of Neuroprotective Agents
por: L. Shahsuvaryan, Marianne
Publicado: (2013)